These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28538743)

  • 41. Hidradenitis Suppurativa: A Guide for the Practicing Physician.
    Woodruff CM; Charlie AM; Leslie KS
    Mayo Clin Proc; 2015 Dec; 90(12):1679-93. PubMed ID: 26653298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hidradenitis suppurativa.
    Danby FW; Margesson LJ
    Dermatol Clin; 2010 Oct; 28(4):779-93. PubMed ID: 20883920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa.
    Mozeika E; Pilmane M; Nürnberg BM; Jemec GB
    Acta Derm Venereol; 2013 May; 93(3):301-4. PubMed ID: 23096596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hidradenitis suppurativa.
    Sabat R; Jemec GBE; Matusiak Ł; Kimball AB; Prens E; Wolk K
    Nat Rev Dis Primers; 2020 Mar; 6(1):18. PubMed ID: 32165620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Update on Hidradenitis Suppurativa (Part I): Epidemiology, Clinical Aspects, and Definition of Disease Severity.
    Martorell A; García-Martínez FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodriguez J; Salgado L; Vilarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):703-15. PubMed ID: 26254550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aetiology and pathogenesis of hidradenitis suppurativa.
    Wolk K; Join-Lambert O; Sabat R
    Br J Dermatol; 2020 Dec; 183(6):999-1010. PubMed ID: 33048349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
    Nazary M; van der Zee HH; Prens EP; Folkerts G; Boer J
    Eur J Pharmacol; 2011 Dec; 672(1-3):1-8. PubMed ID: 21930119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Major gaps in understanding and treatment of hidradenitis suppurativa.
    Hoffman LK; Ghias MH; Garg A; Hamzavi IH; Alavi A; Lowes MA
    Semin Cutan Med Surg; 2017 Jun; 36(2):86-92. PubMed ID: 28538750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical analysis of steroid hormone receptors in hidradenitis suppurativa.
    Buimer MG; Wobbes T; Klinkenbijl JH; Reijnen MM; Blokx WA
    Am J Dermatopathol; 2015 Feb; 37(2):129-32. PubMed ID: 25229569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic associations of hidradenitis suppurativa.
    Kohorst JJ; Kimball AB; Davis MD
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S27-35. PubMed ID: 26470611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing patients with hidradenitis suppurativa.
    Ball SL; Tidman MJ
    Practitioner; 2016 May; 260(1793):25-9, 3. PubMed ID: 27382916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hedgehog pathway does not play a role in hidradenitis suppurativa pathogenesis.
    Mozeika E; Jemec GB; Nürnberg BM
    Exp Dermatol; 2011 Oct; 20(10):841-2. PubMed ID: 21824197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage.
    Campanati A; Martina E; Giuliodori K; Bobyr I; Consales V; Offidani A
    Dermatol Ther; 2019 May; 32(3):e12841. PubMed ID: 30693648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis.
    von Laffert M; Helmbold P; Wohlrab J; Fiedler E; Stadie V; Marsch WC
    Exp Dermatol; 2010 Jun; 19(6):533-7. PubMed ID: 19659829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature.
    Hoffman LK; Tomalin LE; Schultz G; Howell MD; Anandasabapathy N; Alavi A; Suárez-Fariñas M; Lowes MA
    PLoS One; 2018; 13(9):e0203672. PubMed ID: 30265680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa.
    Frew JW; Navrazhina K; Marohn M; Lu PC; Krueger JG
    Exp Dermatol; 2019 Aug; 28(8):886-891. PubMed ID: 31140657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful use of brachytherapy for a severe hidradenitis suppurativa variant.
    Paul S; Bach D; LeBoeuf NR; Devlin PM; Lipworth AD
    Dermatol Ther; 2016 Nov; 29(6):455-458. PubMed ID: 27425163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic hidradenitis suppurativa and perianal mucinous adenocarcinoma. A case report.
    do Val IC; Almeida Filho GL; Corrêa A; Neto N
    J Reprod Med; 2007 Feb; 52(2):100-2. PubMed ID: 17393769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should Hidradenitis Suppurativa Be Included in Dermatoses Showing Koebnerization? Is It Friction or Fiction?
    Boer J
    Dermatology; 2017; 233(1):47-52. PubMed ID: 28505620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.